Trial Information
Association Between Hepatitis C Infection and Renal Cell Carcinoma, a Case Control Study
Inclusion Criteria:
- Male and female patients 18 years or older in whom renal cell carcinoma is suspected
and are scheduled for either biopsy or partial or total nephrectomy. Diagnosis within
6 months.
- Male and female patients 18 years or older in whom colorectal cancer has been
diagnosed within the last 6 months
Exclusion Criteria:
- Patients who are unwilling to provide consent
- Patients who decline to complete a questionnaire
- Patient in who blood sample cannot be obtained
- Diagnosis of renal cell carcinoma or colon cancer greater than 6 months
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Outcome Measure:
Prevalence of hepatitis C in renal cell carcinoma patients
Outcome Description:
Determine the prevalence of hepatitis C infection in newly diagnosed renal cell carcinoma patients
Outcome Time Frame:
2 years
Safety Issue:
No
Principal Investigator
Humberto C Gonzalez, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Henry Ford Hospital
Authority:
United States: Institutional Review Board
Study ID:
P08406
NCT ID:
NCT01405183
Start Date:
January 2011
Completion Date:
Related Keywords:
- Hepatitis C
- Renal Cell Carcinoma
- Colorectal Cancer
- Hepatitis C
- Renal Cell Carcinoma
- Colorectal Cancer
- Carcinoma
- Carcinoma, Renal Cell
- Colorectal Neoplasms
- Hepatitis
- Hepatitis A
- Hepatitis C
Name | Location |
Henry Ford Hospital |
Detroit, Michigan 48202 |